Mavrilimumab
Mavrilimumab is a human monoclonal antibody that is designed for the treatment of rheumatoid arthritis. It is an immunoglobulin G4, anti-granulocyte macrophage colony-stimulating factor (GM-CSF) receptor α monoclonal antibody. Mavrilimumab was developed by MedImmune, a subsidiary of AstraZeneca.
Mechanism of Action[edit]
Mavrilimumab works by binding to the alpha chain of the GM-CSF receptor, inhibiting GM-CSF signaling. GM-CSF is a cytokine that plays a crucial role in inflammation and autoimmunity, including the pathogenesis of rheumatoid arthritis.
Clinical Trials[edit]
Mavrilimumab has undergone Phase IIb clinical trials for rheumatoid arthritis. The results showed that the drug was well-tolerated and led to improvements in disease activity. It is currently undergoing Phase III trials.
COVID-19 Treatment[edit]
In 2020, mavrilimumab was investigated as a potential treatment for COVID-19. Preliminary results from a small, single-center, open-label study in Italy suggested that mavrilimumab may reduce the risk of respiratory failure and death in patients with severe COVID-19 pneumonia.
See Also[edit]
References[edit]
<references />
| Cytokine receptor modulators | ||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
 | This medical article is a stub. You can help WikiMD by expanding the page. |
| This medical article is a stub. You can help WikiMD by expanding the page. |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
